PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3104258-7 1987 From these results, it was suggested that high-spin forms of cytochrome P-450 (MC-P-448-H and P-448 ham-II) played an important role in the metabolic activation of phenacetin to the direct-acting mutagens. Phenacetin 164-174 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 61-77 15231049-2 2004 Using rat cDNA-expressed cytochrome P450 (CYP) enzymes, we found that phenacetin biotransformation was primarily mediated by CYP2C6 and CYP1A isoforms, while chlorzoxazone biotransformation was largely mediated by CYP2E1 and CYP1A1. Phenacetin 70-80 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 25-40 15231049-2 2004 Using rat cDNA-expressed cytochrome P450 (CYP) enzymes, we found that phenacetin biotransformation was primarily mediated by CYP2C6 and CYP1A isoforms, while chlorzoxazone biotransformation was largely mediated by CYP2E1 and CYP1A1. Phenacetin 70-80 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 42-45 3104258-0 1987 Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters. Phenacetin 24-34 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 71-87 3104258-2 1987 Five different molecular species of cytochrome P-450 have been purified from liver microsomes of drug-pretreated Wistar rats or Syrian hamsters and their abilities to activate phenetidine and phenacetin were compared using reconstituted microsome systems. Phenacetin 192-202 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 36-52 3729972-3 1986 Microsomal monooxygenase heterogeneity is also shown to provide a plausible explanation of other published results signifying the departure of chloramphenicol and phenacetin from the concept of competitive inhibition despite competition with substrate for the active-site haem group of cytochrome P-450. Phenacetin 163-173 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 286-302 30219678-12 2018 The metabolic capacity of CYP450 was evaluated using five probe drugs, phenacetin, tolbutamide, metoprolol, midazolam, and bupropion. Phenacetin 71-81 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 26-32 23444776-3 2013 Phenacetin, coumarin, tolbutamide, chlorzoxazone and testosterone are commonly used as probe substrates to evaluate cytochrome P450 function. Phenacetin 0-10 cytochrome P450, family 2, subfamily g, polypeptide 1 Rattus norvegicus 116-131